Greensboro, NC, United States of America

Bapu Reddy Gaddam

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Greensboro, NC (US) (2009 - 2012)
  • High Point, NC (US) (2011 - 2015)
  • Ellicott City, MD (US) (2016 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Bapu Reddy Gaddam: Innovator in Pharmaceutical Metabolites

Introduction

Bapu Reddy Gaddam, based in Greensboro, North Carolina, is an accomplished inventor with a total of 19 patents. His work primarily focuses on the development of innovative pharmaceutical compounds, particularly those related to metabolites that demonstrate significant biological activity.

Latest Patents

One of Gaddam's latest patents revolves around the metabolites of a compound known as [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine. This invention highlights the potential of these metabolites as RAGE antagonists, indicating their role in controlling receptor for advanced glycation end-products. Furthermore, these metabolites are pivotal in assays designed to measure their presence or concentration in various samples, showcasing their value in pharmaceutical research and development.

Career Highlights

Throughout his career, Gaddam has made significant contributions to the field of pharmaceuticals. He has worked with notable companies, including VTV Therapeutics LLC and High Point Pharmaceuticals, LLC, where his expertise in metabolite research has been instrumental in developing innovative therapeutic solutions.

Collaborations

In his journey as an inventor, Gaddam has collaborated with numerous professionals, including coworkers Adnan M M Mjalli and Dharma Rao Polisetti. These partnerships have allowed him to enhance his research and push the boundaries of pharmaceutical innovation.

Conclusion

Bapu Reddy Gaddam exemplifies the spirit of innovation in the field of pharmaceuticals. With 19 patents to his name and a focus on developing metabolites that hold therapeutic promise, Gaddam continues to make strides that could lead to groundbreaking advancements in medicine. His collaborative efforts and career experiences further underscore his impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…